Related Experiment Video
Updated: Sep 22, 2025
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.9K
Vagus nerve stimulation for conservative therapy-refractive epilepsy and depression
H Möbius1,2, H J Welkoborsky1,2
1Klinik für HNO-Heilkunde, Kopf- und Halschirurgie, KRH Klinikum Nordstadt, Hannover.
Laryngo- Rhino- Otologie
|May 23, 2022
Summary
Vagus nerve stimulation (VNS) offers a safe, well-tolerated neuromodulatory therapy for drug-resistant epilepsy and depression. While not a cure, VNS can improve quality of life and reduce seizure frequency, with ongoing research exploring broader applications.
Area of Science:
- Neuromodulation
- Epilepsy treatment
- Depression management
Background:
- Vagus nerve stimulation (VNS) is an established therapy for drug-resistant epilepsy and depression.
- It serves as an indirect neuromodulatory approach using electrically induced currents.
- VNS is considered cost-effective within an interdisciplinary treatment framework.
Purpose of the Study:
- To review the efficacy, safety, and tolerance of VNS for refractory epilepsy and depression.
- To explore the functional principles and potential benefits of VNS.
- To discuss current technical advancements and future research directions for VNS.
Main Methods:
- Review of long-term data on invasive vagus nerve stimulation (iVNS) trials.
- Comparison of invasive and transcutaneous VNS (tVNS) effectiveness.
- Analysis of VNS effects on cognitive function, quality of life, and other conditions.
Main Results:
- VNS is generally safe and well-tolerated, with manageable side effects.
- Both iVNS and tVNS demonstrate antiepileptic and antidepressant effects, with VNS positively impacting cognition.
- iVNS offers palliative seizure reduction, not a cure, and new systems may reduce SUDEP risk.
- tVNS shows lower efficacy compared to iVNS for epilepsy and depression.
- Emerging evidence suggests VNS benefits in immunological, cardiological, and gastroenterological conditions.
Conclusions:
- Invasive VNS is a safe and effective palliative option for refractory epilepsy and depression, improving quality of life.
- Ongoing research is expanding VNS applications to other medical fields.
- Further studies are needed to confirm the efficacy of tVNS and other VNS indications.
Related Concept Videos
01:30Electroconvulsive Therapy
212
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
212
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
468
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
468